ADP/ATP translocase 4

From WikiMD's WELLNESSPEDIA

ADP/ATP translocase 4 (also known as ANT4) is a protein that in humans is encoded by the SLC25A31 gene. It is a member of the adenine nucleotide translocator family of proteins, which play a crucial role in the mitochondrial adenosine triphosphate (ATP) production process.

Function[edit]

ANT4 is an adenine nucleotide translocator that is primarily expressed in testis and spermatozoa. It plays a vital role in the transport of adenosine diphosphate (ADP) into the mitochondria and the export of adenosine triphosphate (ATP) from the mitochondria to the cytosol. This exchange of ADP and ATP across the mitochondrial inner membrane is essential for cellular energy production.

Structure[edit]

The ANT4 protein is composed of 298 amino acids and has a molecular weight of approximately 33 kDa. It contains six transmembrane domains and a signature motif, which is characteristic of the adenine nucleotide translocator family. The protein structure allows it to form a channel in the mitochondrial inner membrane, facilitating the transport of ADP and ATP.

Clinical Significance[edit]

Mutations in the SLC25A31 gene that encodes ANT4 have been associated with various medical conditions. For instance, they have been linked to male infertility due to a decrease in sperm motility. Additionally, ANT4 has been implicated in the pathogenesis of Parkinson's disease, as it may contribute to mitochondrial dysfunction, a key feature of this neurodegenerative disorder.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.